메뉴 건너뛰기
International Journal of Biological Markers
Volumn 26, Issue 4, 2011, Pages 274-275
Vascular endothelial growth factor (VEGF) +936 C/T gene polymorphism and gastric cancer risk: Appraisal of a recent meta-analysis
Author keywords

[No Author keywords available]
Indexed keywords

VASCULOTROPIN;
EID: 84555203843     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2011.8829     Document Type: Letter
Times cited : (5)
References (8)
  • 1
    • 78650821377 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF) +936 C/T gene polymorphisms and gastric cancer risk: A meta-analysis involving 4,138 subjects
    • Zhou Y, Hu W, Zhuang W, et al. Vascular endothelial growth factor (VEGF) +936 C/T gene polymorphisms and gastric cancer risk: a meta-analysis involving 4,138 subjects. Int J Biol Markers 2010; 25: 213-8.
    • (2010) Int J Biol Markers , vol.25 , pp. 213-218
    • Zhou, Y.1    Hu, W.2    Zhuang, W.3
  • 2
    • 47649088499 scopus 로고    scopus 로고
    • Potentially functional polymorphisms of the vascular endothelial growth factor gene and risk of gastric cancer
    • Ke Q, Liang J, Wang LN, et al. Potentially functional polymorphisms of the vascular endothelial growth factor gene and risk of gastric cancer. Mol Carcinog 2008; 47: 647-51.
    • (2008) Mol Carcinog , vol.47 , pp. 647-651
    • Ke, Q.1    Liang, J.2    Wang, L.N.3
  • 3
    • 68549101842 scopus 로고    scopus 로고
    • The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration
    • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700.
    • (2009) BMJ , vol.339
    • Liberati, A.1    Altman, D.G.2    Tetzlaff, J.3
  • 4
    • 58149464322 scopus 로고    scopus 로고
    • Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer
    • Bae SJ, Ahn DH, Hong SP, et al. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer. Yonsei Med J 2008; 49: 783-91.
    • (2008) Yonsei Med J , vol.49 , pp. 783-791
    • Bae, S.J.1    Ahn, D.H.2    Hong, S.P.3
  • 5
    • 0033865580 scopus 로고    scopus 로고
    • Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production
    • Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000; 12: 1232-5.
    • (2000) Cytokine , vol.12 , pp. 1232-1235
    • Watson, C.J.1    Webb, N.J.2    Bottomley, M.J.3    Brenchley, P.E.4
  • 6
    • 42549161440 scopus 로고    scopus 로고
    • Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea
    • Bae SJ, Kim JW, Kang H, Hwang SG, Oh D, Kim NK. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res 2008; 28: 1271-6.
    • (2008) Anticancer Res , vol.28 , pp. 1271-1276
    • Bae, S.J.1    Kim, J.W.2    Kang, H.3    Hwang, S.G.4    Oh, D.5    Kim, N.K.6
  • 7
    • 0042594475 scopus 로고    scopus 로고
    • A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk
    • Krippl P, Langsenlehner U, Renner W, et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003; 106: 468-71.
    • (2003) Int J Cancer , vol.106 , pp. 468-471
    • Krippl, P.1    Langsenlehner, U.2    Renner, W.3
  • 8
    • 77955868556 scopus 로고    scopus 로고
    • Can gastric cancer be prevented?
    • Tepes B. Can gastric cancer be prevented? J Physiol Pharmacol 2009; 60: 71-7.
    • (2009) J Physiol Pharmacol , vol.60 , pp. 71-77
    • Tepes, B.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.